Vivos Therapeutics Inc
(NAS:VVOS)
$
0.49
+0.042 (+9.34%)
Market Cap: 6.85 Mil
Enterprise Value: 16.88 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 41/100 Vivos Therapeutics Inc at Benzinga Global Small Cap Investor Conference (Virtual) Transcript
Dec 09, 2021 / 06:55PM GMT
Release Date Price:
$71.5
(+2.14%)
Brent Slava
Benzinga - Moderator
And I want to bring on Vivos Therapeutics' Co-Founder and CEO, Kirk Huntsman. Kirk, nice to see you here.
Kirk Huntsman
Vivos Therapeutics, Inc. - Chairman & CEO
Hi, Brent. Nice to be here. Thanks for having us.
Brent Slava
Benzinga - Moderator
Yeah. And it looks like your CFO, Brad, is also here. Nice to meet you, Brad. Nice to see you.
Brad Amman
Vivos Therapeutics, Inc. - CFO
Yeah, good to see you, Brent.
Brent Slava
Benzinga - Moderator
Cool. Well, I will let you guys have at it. I see some slides backstage and who -- whichever one of you guys is controlling that just make it full screen if you can, and we should be good to go.
Kirk Huntsman;Brent Slava
Vivos Therapeutics, Inc. - Chairman & CEO;Benzinga - Moderator
So I thought I did. Let me make sure. How's that? Does that look full screen now?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot